Birrer M

No ORCID on file · 3 papers in corpus
other 2017
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
Gynecologic Oncology ·doi:10.1016/j.ygyno.2017.08.004

PURPOSE: We examined disparities in prognosis between patients with ovarian clear cell carcinoma (OCCC) and serous epithelial ovarian cancer (SOC). METHODS: We reviewed data from FIGO stage I-IV epithelial ovarian cancer patients who parti…

review 2012
Clear cell carcinoma of the ovary: a review of the literature
Gynecologic Oncology ·doi:10.1016/j.ygyno.2012.04.021

OBJECTIVE: Different histologic types of epithelial ovarian cancer may represent different diseases with unique clinical and molecular characteristics. Clear cell carcinoma (CCC) of the ovary has been reported as having a worse prognosis th…

lab-animal 2008
The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers
The Journal of clinical investigation ·doi:10.1172/jci30024

The aryl hydrocarbon receptor repressor (AHRR) is a bHLH/Per-ARNT-Sim transcription factor located in a region of chromosome 5 (5p15.3) that has been proposed to contain one or more tumor suppressor genes. We report here consistent downregu…